Second primary malignancies following the treatment of early stage ovarian cancer: Update of a study by the National Cancer Institute of Canada—Clinical Trials Group (NCIC—CTG)
Open Access
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (1) , 65-68
- https://doi.org/10.1023/a:1008356806417
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)Annals of Oncology, 1995
- Ovarian CancerJAMA, 1995
- Cancer of the OvaryNew England Journal of Medicine, 1993
- Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of Ovarian cancerCancer, 1992
- EditorialGynecologic Oncology, 1991
- Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancerGynecologic Oncology, 1990
- Leukemia Following Chemotherapy for Ovarian CancerNew England Journal of Medicine, 1990
- External beam pelvic radiotherapy plus intraperitoneal radioactive chronic phosphate in early stage ovarian cancer: A toxic combinationInternational Journal of Radiation Oncology*Biology*Physics, 1985
- The role of adjuvant therapy in Stage I ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980
- Ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1979